USP15 stabilizes Lectin Galactoside-Binding Soluble 3 (LGALS3) by blocking its ubiquitin-proteasome system-mediated degradation, thereby activating the AKT/mTOR axis to promote cancer stemness, proliferation, and lenvatinib resistance. The gene discussed is AKT1; the disease is cancer.